It is not approved for human or animal use , and may not be used in food, drugs, cosmetics, or diagnostic applications
The preclinical evidence: what the studies actually show Honest assessment of the evidence requires separating what has been demonstrated from what has been assumed
doi: 10.1111/dom.15318 61
Inclusion criteria: (1) all meet the diagnostic criteria for chronic hepatitis B
In the SURPASS clinical trial program, which enrolled over 6,000 participants with type 2 diabetes, the most common side effects included nausea (reported in 12% to 29% of patients), diarrhea (13% to 16%), vomiting (5% to 10%), constipation (6% to 7%), and abdominal discomfort
People interested in the science of triple agonism often want to understand how it compares to approved options